Sanofi forms new mRNA vaccines unit to take the technology beyond Covid-19 June 29, 2021 Auto Bot BioPharma, biopharma nl, France, Paris, Pharma, Sanofi, Vaccines 0 Sanofi, already a global leader in vaccine production, has formed a new division that will focus exclusively on developing messenger RNA vaccines. The pharmaceutical giant is committing to spend €400 million annually on this new center’s mRNA R&D.